Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website
Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) | Official Website
This is a 50% decrease from the number of companies inspected in the previous quarter, when 12 companies received 13 inspections.
Most of the companies inspected at the time were involved in the Biologics sector. The Devices and Drugs sectors sectors, along with one other sector, tied for second most common type.
There were five companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Creative Testing Solutions | Biologics | 08/31/2023 | No Action Indicated (NAI) |
Jost Chemical Company | Drugs | 08/25/2023 | No Action Indicated (NAI) |
Jost Chemical Company | Food and Cosmetics | 08/25/2023 | No Action Indicated (NAI) |
Jost Chemical Company | Veterinary | 08/25/2023 | No Action Indicated (NAI) |
Ravi Vij, M.D. | Biologics | 07/17/2023 | No Action Indicated (NAI) |
TJ's Pizza Company | Food and Cosmetics | 08/02/2023 | Voluntary Action Indicated (VAI) |
Turing Medical Technologies, Inc. | Devices | 08/02/2023 | No Action Indicated (NAI) |
Washington University Human Research Protections Office | Biologics | 08/04/2023 | No Action Indicated (NAI) |
Washington University Human Research Protections Office | Devices | 08/04/2023 | No Action Indicated (NAI) |
Washington University Human Research Protections Office | Drugs | 08/04/2023 | No Action Indicated (NAI) |